跳至主要内容
临床试验/NCT00203918
NCT00203918已完成不适用

Prostate Cancer Utilities and Cost-Effectiveness Analysis

University of Chicago1 个研究点 分布在 1 个国家目标入组 481 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
481
试验地点
1
主要终点
Utility scores for treatment outcomes

研究概览

简要总结

The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.

详细描述

The goal of this project is to incorporate patients' preferences into a previously developed prostate cancer treatment decision-model and to understand the implications for doing so for cost-effectiveness analysis. To do this, it is first necessary to obtain patient utility scores (i.e., patient preference weights). To do this we will perform a survey of patients visiting the urology clinic to undergo prostate biopsies to validate a method of utility assessment, and understand the patients' individual evaluations of treatment-related health studies. We will also ask patients questions relating to their anxiety levels concerning the possible diagnosis of prostate cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients undergoing prostate biopsy

排除标准

  • Women and children will be excluded, as prostate cancer occurs in men only
  • Diagnosis of dementia

结局指标

主要结局

Utility scores for treatment outcomes

时间窗: 90 days after enrollment

Patient utility scores (i.e. patient preference weights) are calculated using survery data will determine which prostate cancer treatment would be most cost-effective for each subject. Patients will be contacted by phone and patient records will be reviewed 90 days after the survey has been completed to determine whether this data reflects actual treatment decisions.

次要结局

  • Anxiety levels(90 days after enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验